Copyright
©The Author(s) 2021.
World J Gastroenterol. May 28, 2021; 27(20): 2434-2457
Published online May 28, 2021. doi: 10.3748/wjg.v27.i20.2434
Published online May 28, 2021. doi: 10.3748/wjg.v27.i20.2434
Figure 3 Current treatment recommendations based on the Barcelona clinic liver cancer stage and the potential roles of radiotherapy.
HCC: Hepatocellular carcinoma; BCLC: Barcelona clinic liver cancer; PS: Performance status; TACE: trans-arterial chemoembolization; TARE: Trans-arterial radioembolization; HAIC: Hepatic arterial infusion chemotherapy; RT: Radiotherapy; CFRT: Conventionally fractionated radiotherapy; HFRT: Hypo-fractionated radiotherapy; SBRT: Stereotactic body radiation therapy; PVT: Portal vein thrombosis; STAR effect: Systemic therapy augmented by radiotherapy effect.
- Citation: Chen LC, Lin HY, Hung SK, Chiou WY, Lee MS. Role of modern radiotherapy in managing patients with hepatocellular carcinoma. World J Gastroenterol 2021; 27(20): 2434-2457
- URL: https://www.wjgnet.com/1007-9327/full/v27/i20/2434.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i20.2434